Andrew R Pachner Selected Research

Andrew R Pachner Research Topics

18	Multiple Sclerosis 01/2021 - 11/2003
6	Inflammation (Inflammations) 01/2021 - 09/2002
6	Infections 01/2017 - 07/2005
5	Demyelinating Diseases (Demyelinating Disease) 05/2019 - 03/2011
2	Neuroinflammatory Diseases 01/2019 - 02/2016
2	Relapsing-Remitting Multiple Sclerosis 12/2017 - 07/2010
2	Virus Diseases (Viral Diseases) 12/2017 - 12/2015
2	Persistent Infection 12/2015 - 06/2005
2	Lyme Neuroborreliosis 06/2005 - 03/2005
1	Disease Susceptibility (Diathesis) 01/2020
1	Nervous System Diseases (Neurological Disorders) 11/2019
1	Disease Progression 12/2017
1	Encephalomyelitis (Myeloencephalitis) 12/2017
1	Spinal Cord Diseases 01/2016
1	Chronic Disease (Chronic Diseases) 12/2015
1	Communicable Diseases (Infectious Diseases) 12/2015
1	Crohn Disease (Crohn's Disease) 01/2015
1	Lymphoma (Lymphomas) 01/2015
1	Vasculitis (Vasculitides) 12/2011
1	Vocal Cord Paralysis 12/2011
1	Neuromyelitis Optica (Devic's Disease) 12/2011
1	Meningoencephalitis 03/2011
1	Myasthenia Gravis 07/2004
1	Lyme Disease (Disease, Lyme) 09/2002
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2002

6	Interferon-betaIBA 12/2017 - 11/2003
5	Biomarkers (Surrogate Marker)IBA 10/2020 - 12/2015
5	AntibodiesIBA 01/2017 - 11/2003
4	Neutralizing AntibodiesIBA 09/2018 - 11/2008
3	ChemokinesIBA 05/2019 - 09/2002
3	Antiviral Agents (Antivirals)IBA 12/2017 - 01/2017
3	Immunoglobulin G (IgG)IBA 01/2017 - 06/2005
3	CytokinesIBA 12/2015 - 09/2002
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 07/2005
2	Oligoclonal BandsIBA 01/2019 - 12/2011
2	Complement System Proteins (Complement)IBA 07/2005 - 12/2003
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2004 - 12/2003
2	Hematoxylin (Haematoxylon)IBA 02/2004 - 12/2003
1	AlbuminsIBA 01/2021
1	Serum AlbuminIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020
1	teriflunomideIBA 12/2017
1	Monoclonal AntibodiesIBA 12/2015
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2015
1	Bendamustine Hydrochloride FDA Link 01/2015
1	Natalizumab (Tysabri)FDA Link 01/2015
1	Rituximab (Mabthera)FDA Link 01/2015
1	Fingolimod Hydrochloride (FTY720)FDA Link 09/2011
1	Immunoglobulins (Immunoglobulin)IBA 03/2011
1	Immunomodulating AgentsIBA 07/2010
1	GadoliniumIBA 11/2009
1	Interferon beta-1b (Betaseron)FDA Link 11/2009
1	Glatiramer Acetate (Copaxone)FDA Link 11/2009
1	ElementsIBA 03/2009
1	Biological ProductsIBA 11/2007
1	Viral RNAIBA 04/2007
1	Therapeutic UsesIBA 02/2006
1	Complement Factor H (Factor H)IBA 07/2005
1	4,5-dibromo-2-pyrrolic acidIBA 06/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2005
1	AntigensIBA 07/2004
1	Chemotactic FactorsIBA 09/2002